Skip to content

Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy

Impact of Yoga As Complementary Therapy on Quality of Life, Pro-inflammatory, and Cellular Immune Biomarkers in Patients Undergoing Radical Prostatectomy: A Pilot Randomized-Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02620033
Enrollment
30
Registered
2015-12-02
Start date
2015-09-01
Completion date
2021-12-31
Last updated
2022-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostatectomy, Yoga therapy, Health related quality of life

Brief summary

The researchers hope to learn if yoga complementary therapy would improve health-related quality of life, recovery of urinary continence and erectile function in patients who underwent prostate cancer surgery (i.e. radical prostatectomy). We hypothesized that in patients undergoing radical prostatectomy, preoperative and postoperative Yoga complementary therapy would improve health- related quality of life (HRQOL), recovery of urinary continence and erectile function. This two-arm, randomized controlled pilot study will compare Yoga intervention to usual care group. The aim is to evaluate the efficacy of Yoga complementary therapy on HRQOL in patients who underwent radical prostatectomy (RP). Yoga therapy will be given to the intervention group three times in a week for 6 weeks prior to surgery and then initiated 3 weeks after the surgery for another 6 weeks. The yoga exercise will be tailored to the participant's comfort level. As an exploratory analysis, we will evaluate pro-inflammatory and immunological markers.

Interventions

BEHAVIORALYoga therapy

Sponsors

The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Men between the age of 30 to 80 * Has been diagnosed with localized prostate cancer (i.e. pathologically and/or radiographically confirmed) * Is scheduled to undergo radical prostatectomy (i.e. robot-assisted or open-approach) * Has no other active primary malignancy aside from prostate cancer * Currently not practicing yoga as a form of exercise and/or meditation * Does not have uncontrolled pain * Does not have neurological or musculoskeletal co-morbidity inhibiting exercise * Has never been diagnosed by health care professionals to have absolute contraindications to exercise testing * Willing to be randomized to either standard care or intervention group * Willing to participate in yoga therapy for twelve weeks if randomized to intervention group * Willing to undergo phlebotomy * Able and willing to provide informed consent

Exclusion criteria

* Men under the age of 30 or over the age of 80 * Has NOT been diagnosed with localized prostate cancer (i.e. pathologically and/or radiographically confirmed) * Is NOT scheduled to undergo radical prostatectomy (i.e. robot-assisted or open-approach) * Has other active primary malignancy aside from prostate cancer * Currently practicing yoga as a form of exercise and/or meditation * Has uncontrolled pain * Has neurological or musculoskeletal co-morbidity inhibiting exercise * Has been diagnosed with psychotic, addictive, and major cognitive disorders * Has been diagnosed by health care professionals to have absolute contraindications to exercise testing Unwilling to be randomized to either standard care or intervention group * Unwilling to participate in yoga therapy for twelve weeks if randomized to intervention group * Unwilling to undergo phlebotomy * Unable and unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in 6-minute walk testOne year
Total number of participants completed the studyOne year
Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0One year
Change from baseline in health related quality of life measuresOne yearhealth related quality of life measures including but not limited to fatigue level, recovery urinary continence, and erectile function.
Total number of participants recruited to and withdraw from the studyOne year

Secondary

MeasureTime frame
Change from baseline level on cellular immune response (i.e. measuring the Natural Killer Cell and regulatory-T cells)One year
Change from baseline level on pro-inflammatory biomarkersone year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026